Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience

被引：0
作者：
Naoko Ishida
Kazuhiro Araki
Takehiko Sakai
Kokoro Kobayashi
Takayuki Kobayashi
Ippei Fukada
Mitsuchika Hosoda
Mitsugu Yamamoto
Kazuomi Ichinokawa
Shunji Takahashi
Takuji Iwase
Yoshinori Ito
Hiroko Yamashita
机构：
[1] Hokkaido University Hospital,Breast Surgery
[2] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Breast Medical Oncology
[3] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Surgical Oncology, Breast Oncology Center
[4] Cancer Institute Hospital of the Japanese Foundation for Cancer Research,Medical Oncology
来源：
Breast Cancer | 2016年 / 23卷
关键词：
Fulvestrant; Metastatic breast cancer; Advanced breast cancer; Postmenopausal; Endocrine therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：617 / 623
页数：6
相关论文
共 50 条
[21]   Fulvestrant ('Faslodex') in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme [J].
Mlineritsch, Brigitte ;
Psenak, Oskar ;
Mayer, Peter ;
Moik, Martin ;
Namberger, Konrad ;
Hauser-Kronberger, Cornelia ;
Greil, Richard .
BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 (01) :105-112
[22]   Efficacy of fulvestrant 500 mg in Japanese postmenopausal advanced/recurrent breast cancer patients and factors associated with prolonged time-to-treatment failure [J].
Araki, Kazuhiro ;
Ishida, Naoko ;
Horii, Rie ;
Takahashi, Shunji ;
Akiyama, Futoshi ;
Ito, Yoshinori ;
Ohno, Shinji .
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (17) :2561-2568
[23]   Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review [J].
Jennifer Flemming ;
Yolanda Madarnas ;
Jacob A. Franek .
Breast Cancer Research and Treatment, 2009, 115
[24]   Case studies of fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer [J].
Abram, P ;
Maass, N ;
Rea, D ;
Simon, SD ;
Steger, GG .
CANCER TREATMENT REVIEWS, 2005, 31 :S17-S25
[25]   Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients [J].
Freedman, Orit ;
Amir, Eitan ;
Dranitsaris, George ;
Napolskikh, Julie ;
Kumar, Ritu ;
Fralick, Michael ;
Chia, Stephen ;
Petrella, Teresa ;
Dent, Susan ;
Tonkin, Katia ;
Ahmad, Imran ;
Rayson, Daniel ;
Clemons, Mark .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (02) :377-383
[26]   Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients [J].
Orit Freedman ;
Eitan Amir ;
George Dranitsaris ;
Julie Napolskikh ;
Ritu Kumar ;
Michael Fralick ;
Stephen Chia ;
Teresa Petrella ;
Susan Dent ;
Katia Tonkin ;
Imran Ahmad ;
Daniel Rayson ;
Mark Clemons .
Breast Cancer Research and Treatment, 2009, 118 :377-383
[27]   Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience [J].
Li, Yi ;
Xie, Yizhao ;
Gong, Chengcheng ;
Zhao, Yannan ;
Zhang, Jian ;
Zhang, Sheng ;
Wang, Leiping ;
Chen, She ;
Hu, Xichun ;
Wang, Biyun .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 :607-615
[28]   Benefits of early and prolonged fulvestrant treatment in 848 postmenopausal advanced breast cancer patients [J].
Mathias Warm ;
Ronald Kates ;
Friedrich Overkamp ;
Anke Thomas ;
Nadia Harbeck .
Breast Cancer Research and Treatment, 2011, 125 :127-136
[29]   Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant [J].
Morales, Leilani ;
Neven, Patrick ;
Timmerman, Dirk ;
Wildiers, Hans ;
Konstantinovic, Maja L. ;
Christiaens, Marie-Rose ;
Tan, Peter N. ;
Paridaens, Robert .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (01) :77-81
[30]   Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant [J].
Leilani Morales ;
Patrick Neven ;
Dirk Timmerman ;
Hans Wildiers ;
Maja L. Konstantinovic ;
Marie-Rose Christiaens ;
Peter N. Tan ;
Robert Paridaens .
Breast Cancer Research and Treatment, 2009, 117
12345